A large database study of hospitalization charges and follow-up re-admissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

BACKGROUND: The objective of this study was to retrospectively compare initial procedure and 12-month follow-up hospitalization charges and resource utilization (lengths of stay; LOS) for lumbar fusion surgeries using either recombinant human bone morphogenetic protein-2 (rhBMP-2) or a cellular bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetzell, Bradley, McLean, Julie B., Moore, Mark A., Kondragunta, Venkateswarlu, Dorsch, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678152/
https://www.ncbi.nlm.nih.gov/pubmed/33213484
http://dx.doi.org/10.1186/s13018-020-02078-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678152/
https://www.ncbi.nlm.nih.gov/pubmed/33213484
http://dx.doi.org/10.1186/s13018-020-02078-7

Ejemplares similares